North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Brigatinib Intermediate 1197953-47-1</strong> is a key synthetic building block for the anaplastic lymphoma kinase (ALK) inhibitor Brigatinib. Manufactured via advanced heterocyclic coupling, its molecular formula is C22H24ClN5O2. This high-purity API intermediate ensures efficient downstream synthesis.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical manufacturing as a primary precursor for ALK inhibitor production.</li>
<li>Research and development of novel non-small cell lung cancer (NSCLC) therapies.</li>
<li>Quality control standardization in active pharmaceutical ingredient supply chains.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at controlled temperatures below 25°C to prevent degradation. Handle with appropriate PPE to avoid skin contact or inhalation of dust particles during industrial processing.</p>